Yeşim AYDINOK
Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Çocuk Sağlığı Ve Hastalıkları Anabilim Dalı
Araştırma alanları: Sağlık Bilimleri, Tıp, Dahili Tıp Bilimleri, Çocuk Sağlığı ve Hastalıkları, Pediatrik Hematoloji, İç Hastalıkları, Hematoloji, Temel Tıp Bilimleri, Temel Bilimler, Yaşam Bilimleri
Yayınlar
- Phase 2a randomized study to evaluate sapablursen in patients with non-transfusion dependent β-thalassemia intermedia (2026)
- Avatrombopag for persistent and chronic immune thrombocytopenia in children: A post hoc analysis of clinical characteristics of response from a phase 3b clinical trial (2026)
- Avatrombopag for treating children and adolescents with immune thrombocytopenia: a plain language summary (2025)
- Luspatercept versus mitapivat for non‐transfusion‐dependent β‐thalassemia: Dare to compare? (2025)
- Avatrombopag for the treatment of children and adolescents with immune thrombocytopenia (AVA-PED-301): a multicentre, randomised, double-blind, placebo-controlled, phase 3b study (2025)
- Mitapivat in adults with non-transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE): a phase 3, international, randomised, double-blind, placebo-controlled trial (2025)
- Systematic literature review of the indirect costs and humanistic burden of β-thalassemia (2024)
- ENERGIZE: A GLOBAL PHASE 3 STUDY OF MITAPIVAT DEMONSTRATING EFFICACY AND SAFETY IN ADULTS WITH ALPHA- OR BETA-NON–TRANSFUSION-DEPENDENT THALASSEMIA (2024)
- IMPROVEMENTS IN FATIGUE AND 6-MINUTE WALK TEST IN ADULTS WITH ALPHA- OR BETA-NON–TRANSFUSION-DEPENDENT THALASSEMIA: THE PHASE 3 ENERGIZE TRIAL OF MITAPIVAT (2024)
- Evaluation of the Effectiveness of Convalescent Plasma Therapy in Severe and Critical COVID-19 (2024)
- Evaluation of the Effectiveness of Convalescent Plasma Therapy in Severe and Critical COVID-19 (2024)
- Invasive Fungal Infections in Children With Acute Myeloid Leukemia: A Single-center Experience Over 19 Years (2023)
- Highlights on the Luspatercept Treatment in Thalassemia (2023)
- Combination chelation therapy (2023)
- Compliance and clinical benefit of deferasirox granule and dispersible tablet formulation in pediatric patients with transfusional iron overload: in a randomized, open-label, multicenter, phase II study (2023)
- Current childhood chronic myeloid leukemia management under tyrosine kinase inhibitor treatment (2022)
- Modern Iron Chelation Management of Thalassemia Major Patients Guided by MRI techniques: Real-world Data From a Long-term Cohort Study (2022)
- Correction to: Modern management of iron overload in thalassemia major patients guided by MRI techniques: real‑world data from a long‑term cohort study (2022)
- An open‐label, multicenter, efficacy, and safety study of deferasirox in iron‐overloaded patients with non‐transfusion‐dependent thalassemia ( THETIS ): 5‐year results (2022)
- Thalassaemia (2022)
- P1505: USING ARTIFICIAL INTELLIGENCE NEURAL NETWORKS TO OBTAIN AUTOMATED LIVER IRON CONCENTRATION MEASUREMENTS USING MAGNETIC RESONANCE IMAGING – A MULTI-SCANNER VALIDATION STUDY (2022)
- Hematuria in Patients with Congenital Coagulation Factor Deficiencies (2022)
- The Data from National Register for Surveillance of Standard of Care in Thalassemia in TURKEY (2021)
- Is Monitoring of Cytomegalovirus Disease Required in Nontransplant Pediatric Acute Lymphoblastic Leukemia? (2021)
- Systematic Literature Review of the Indirect Costs, Humanistic Burden, Patient or Caregiver Preference, and Qualitative Outcomes in Beta-Thalassemia (2021)
- VORICONAZOLE PROPHYLAXIS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA (2021)
- TALASEMİ MAJORDA SERUM FERRİTİN EĞİLİMLERİ VE MR İLE DOKU DEMİR DİNAMİKLERİ İLİŞKİSİNİN UZUN SÜRELİ İZLEMİ (2021)
- TREATMENT OF CHRONIC MYELOID LEUKEMIA IN CHILDREN WITH TYROSIN KINASE INHIBITORS (2021)
- THE DATA FROM NATIONAL REGİSTER FOR SURVEILLANCE OF STANDARD OF CARE IN THALASSEMIA IN TURKEY (2021)
- TALASEMİ HASTALARINDA KARACİĞER DEMİR KONSANTRASYONUNUN MRG RELAKSOMETRİ TEKNİKLERİYLE HESAPLANMASI: T2* VE R2 TEKNİĞİNİN KARŞILAŞTIRILMASI (SS-09) (2021)
- Kronik Myeloid Lösemide Tirozin Kinaz İnhibitörünün Kesilmesi Mümkün Mü? (2021)
- Akut Myeloblastik Lösemi Hastalarının Değerlendirilmesi (2021)
- Is Monitoring of Cytomegalovirus Disease Required in Nontransplant Pediatric Acute Lymphoblastic Leukemia? (2021)
- Publisher Correction: Whole-genome sequencing of a sporadic primary immunodeficiency cohort (2020)
- Talasemi Major Olgularında Güncel Yönetim Ölçütlerine Uygun İzlem Normal Büyüme ve Gelişmeyi Desteklemekte midir? (2020)
- A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia (2020)
- Whole-genome sequencing of a sporadic primary immunodeficiency cohort (2020)
- Evaluation of the achievement of hematologists to transfusion medicine education with self-assessment questionnaire in Turkey (2020)
- Recommendations for Pregnancy in Rare Inherited Anemias (2020)
- Is Normal Growth and Development Achieved By Current Management Approaches to Thalassemia Major in the New Era? (2020)
- Evaluation of Liver Iron Content by Magnetic Resonance Imaging in Children with Acute Lymphoblastic Leukemia after Cessation of Treatment (2020)
- Changing patterns in the epidemiology of β‐thalassemia (2020)
- Retrospective Evaluation of Childhood Cutaneous Mastocytosis Cases (2020)
- The effect of virtual reality on pain, fear, and anxiety during access of a port with huber needle in pediatric hematology-oncology patients: Randomized controlled trial (2020)
- Neonatal direk antiglobulin testin yenidoğan hemolitik hastalığını tanımlama ve şiddetini tahmindeki değeri (2019)
- Evaluation of Potential Use of T1 mapping MRI Imaging Technique in the Detection of Iron Overload in Thalassemia Patients: Correlation with T2*, LIC and Serum Ferritin Values (2019)
- Amustaline‐glutathione pathogen‐reduced red blood cell concentrates for transfusion‐dependent thalassaemia (2019)
- Treatment of thalassaemia: a review of the new approaches on transfusion safety and the novel therapeutics (2019)
- Examination of echocardiographic parameters for the early diagnosis of cardiac dysfunction in beta thalassemia major patients (2019)
- Fertility in Patients with Thalassemia and Outcome of Pregnancies: a Turkish Experience (2019)
- HB F YÜKSEKLİĞİNİN NADİR BİR NEDENİ OLAN HOMOZİGOTDELTA BETA TALASEMİLİ BİR OLGU (2018)
- Repeatability of liver iron concentration measurements with MRI and an artificial Neural Network Data Analysis System (2018)
- Iron Chelation Therapy as a Modality of Management (2018)
- MRI for the diagnosis of cardiac and liver iron overload in patients with transfusion‐dependent thalassemia: An algorithm to guide clinical use when availability is limited (2018)
- Optimising management of deferasirox therapy for patients with transfusion‐dependent thalassaemia and lower‐risk myelodysplastic syndromes (2018)
- REPEATABILITY OF LIVER IRON CONCENTRATION MEASUREMENTS WITH MRI AND AN ARTIFICIAL NEURAL NETWORK DATA ANALYSIS SYSTEM (2018)
- HEMOGLOBİN A2 DEĞERİ DÜŞÜK OLGULARDA DELTA GLOBİN GEN VARYANTLARININ ARAŞTIRILMASI: YENİ BİR DELTA GLOBİN VARYANTININ -HBA2 BORNOVA- TANIMLANMASI (2018)
- A National Registry of Thalassemia in Turkey: Demographic and Disease Characteristics of Patients, Achievements, and Challenges in Prevention (2018)
- Two male siblings with a novel LRBA mutation presenting with different findings of IPEX syndrome (2018)
- X’ e bağlı immün yetmezlik-poliendokrinopati (IPEX) fenotipinde başvuran ve yeni tanımlanan LRBA defekti saptanan 2 kardeş olgu (2017)
- Safety and Pharmacokinetics of the Oral Iron Chelator SP-420 in β-thalassemia (2017)
- X-LINKED IMMUNODEFICIENCY-POLYENDOCRINOPATHY-ENTEROPATHY (IPEX)-LIKE PHENOTYPE DUE TO LRBA MUTATIONS IN TWO SIBLINGS (2017)
- ÜÇ OLGU İLE ORAK HÜCRELİ ANEMİ VE HEPATİK SEKESTRASYON. (2017)
- Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: results from a phase 2a study (2017)
- X-LINKED IMMUNODEFICIENCY-POLYENDOCRINOPATHY-ENTEROPATHY (IPEX)-LIKE PHENOTYPE DUE TO LRBA MUTATIONS IN TWO SIBLINGS (2017)
- X’E BAĞLI İMMÜN YETMEZLİK-POLİENDOKRİNOPATİ-ENTEROPATİ (IPEX) FENOTİPİNDE BAŞVURAN VE YENİ TANIMLANAN LRBA DEFEKTİ SAPTANAN İKİ KARDEŞ OLGU (2017)
- HAX 1 mutation positive children presenting with haemophagocytic lymphohistiocytosis (2017)
- Safety and pharmacokinetics of the oral iron chelator SP‐420 in β‐thalassemia (2017)
- Randomized controlled trial of care bundles with chlorhexidine dressing and advanced dressings to prevent catheter-related bloodstream infections in pediatric hematology-oncology patients (2017)
- Akut lenfoblastik lösemi hastalarında t 12 21 TEL AML1 translokasyonunun gerçek zamanlı qRT PZR ile 5 yıllık sonuçlarının değerlendirilmesi (2016)
- Akut Lenfoblastik Lösemi Hastalarında T(12;21) TEL-AML1 Translokasyonunun Gerçek Zamanlı Qrt-PZR İle 5 Yıllık Sonuçlarının Değerlendirilmesi (2016)
- A Randomised 1 Year Study Evaluating the Impact of Vitamin C Supplementation on Systemic Iron Parameters of Iron Overload in Thalassemia Major Patients on Long Term Treatment with Deferasirox (2016)
- Lösemilerde t(9;22) BCR-ABL Translokasyonunun Real-Time RT-PCR ile 10 Yıllık Sonuçlarının Retrospektif Degerlendirilmesi (2016)
- Limitations of serum ferritin to predict liver iron concentration responses to deferasirox therapy in patients with transfusion‐dependent thalassaemia (2016)
- A Randomised 1 Year Study Evaluating the Impact of Vitamin C Supplementation on Systemic Iron Parameters of Iron Overload in Thalassemia Major Patients on Long-Term Treatment with Deferasirox (2016)
- Lösemilerde t(922) BCR-ABL TranslokasyonununReal-Time RT-PCR ile 10 Yıllık SonuçlarınınRetrospektif Değerlendirilmesi (2016)
- Efficacy and Safety of Ruxolitinib in Regularly Transfused Patients with Thalassemia: Results from Single-Arm, Multicenter, Phase 2a Truth Study (2016)
- AKUT MYELOİD LÖSEMİ AML ÖN TANILI OLGULARIN FISHTESTLERİNİN ANALİZİ (2016)
- A Randomised 1 Year Study Evaluating the Impact of Vitamin C Supplementation on Systemic Iron Parameters of Iron Overload in Thalassemia Major Patients on Long-Term Treatment with Deferasirox (2016)
- Optimising iron chelation therapy with deferasirox for non-transfusion-dependent thalassaemia patients: 1-year results from the THETIS study (2016)
- Optimising iron chelation therapy with deferasirox for non-transfusion-dependent thalassaemia patients: 1-year results from the THETIS study (2016)
- MİYELODİSPLASTİK SENDROM MDS ÖN TANILI OLGULARDAİNCELENEN FISH TESTLERİNİN DEĞERLENDİRİLMESİ (2016)
- MLPA YÖNTEMİ İLE ANTİ LEPORE HB P NİLOTİC TANISI KONULAN BİR OLGU (2016)
- Ege Üniversitesi ve Mersin Üniversitesi Tıp Fakültelerinin kan merkezlerine başvuran HBsAg negatif kan vericilerinde HBV-DNA varlığının araştırılması (2016)
- BCR ABL Translokasyonunun Real Time RT PCR ile 10 Yıllık Sonuçlarının Retrospektif Değerlendirilmesi (2016)
- Anaphylaxis due to rFVIIa in an infant suffering from severe congenital FVII deficiency (2016)
- Molecular spectrum of globin gene mutations in the Aegean region of Turkey first observation of three globin gene mutations in the Turkish population (2015)
- Kalıcı Katateri Olan Çocuklar ve Aileleri İçin Evde Bakım Rehberi (2015)
- Hypertension and life threaten bleeding in children wth relapsed AML treated with FLT3 inhibitors (2015)
- AML ön tanılı olgularda inv 16 CBFBETA MYH11 inversiyonunun real time RT PCR ile 5 yıllık sonuçlarının değerlendirilmesi (2015)
- Akut lenfoblastik lösemi hastalarında t 4 11 MLLAF4 translokasyonunun real time RT PCR ile 5 yıllık sonuçlarının retrospektif değerlendirilmesi (2015)
- Successful Treatment With Total Skin Electron Beam Therapy in a Child With Isolated Cutaneous Relapsed AML (2015)
- Association of Liver Iron Concentration Levels with Myocardial T2* Responses in Transfusion-Dependent Thalassemia Major Patients Treated with Deferasirox and Deferoxamine- Extension of Cordelia Study (2015)
- AML ön tanılı olgularda inv(16) CBFBETA-MYH11 inversiyonunun real time RT-PCR ile 5 yıllık sonuçlarının değerlendirilmesi (2015)
- Hypertension and Life-Threatening Bleeding in Children with Relapsed Acute Myeloblastic Leukemia Treated with FLT3 Inhibitors (2015)
- Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overload (2015)
- AML ön tanılı olgularda inv 16 CBFBETA MYH11 İnversiyonunun Real time RT PCR ile 5 Yıllık Sonuçlarının Değerlendirilmesi (2015)
- Optimizing Iron Chelation Therapy with Deferasirox for Non-Transfusion-Dependent Thalassemia Patients: 1-Year Results from the Phase IV, Open-Label Thetis Study (2015)
- Beta Talasemi Major Ve Gebelik. (2015)
- Akut lenfoblastik lösemi hastalarında t(4;11) MLL/AF4 translokasyonunun real time RT-PCR ile 5 yıllık sonuçlarının retrospektif değerlendirilmesi (2015)